Microbiology / Infectious Disease

PACE / State of CA / State of FL
In this month’s “Virtual Lecture” Bobbi Pritt, M.D., shares a series of spooky tales to scare and amaze related to the discovery, characterization, and clinical presentation of notable viruses.

By MCL Education • October 26, 2022

In this month's "Hot Topic," Robin Patel, M.D., discusses how the use of multiplex tests may reduce the turnaround time for identifying the cause of bloodstream infections, and how this might impact antibiotic stewardship and patient outcomes.

By MCL Education • July 11, 2022

In this month's "Hot Topic," Matthew Binnicker, Ph.D., discusses the use of multiplex panels for the diagnosis of respiratory infections and focuses on the clinical utility of these tests in the setting of upper respiratory tract infections.

By MCL Education • June 6, 2022

Elitza Theel, Ph.D., director of the Infectious Diseases Serology Lab at Mayo Clinic, joins the "Answers From the Lab" podcast for a discussion with Bobbi Pritt, M.D. about tick-borne disease testing. In this episode, Dr. Theel and Dr. Pritt look at emerging tick-borne illnesses, the tests available to detect these infections, and how to prevent them.

By Samantha Rossi • May 24, 2022

In this month's "Hot Topic," Elitza Theel, Ph.D., will be discussing laboratory utilization management, specifically for diagnostic testing for tick-borne diseases.

By MCL Education • May 2, 2022

In this month’s “Hot Topic,” Nancy Wengenack, Ph.D., discusses susceptibility testing of yeast for those who are considering performing it in their laboratory, perhaps for the first time, or for those who choose to send their yeast isolates out to a reference laboratory for susceptibility testing but who want to understand how the reference laboratory generates the data that comes back on reports.

By MCL Education • April 25, 2022

With the omicron variant grabbing headlines around the world, media outlets have turned to experts like Dr. Binnicker to help clarify the effect this new variant could have and what it might mean for the COVID-19 pandemic.

By Tracy Will • December 14, 2021

Audrey Schuetz, M.D., discusses Mayo Clinic Laboratories' PCR assay that identifies two recently described staphylococcus species. The assay is unique in its ability to distinguish the new organisms from Staphylococcus aureus, providing clearer results that ultimately improve patient care.

By Samantha Rossi • November 9, 2021

With a spike in cases spurred by the delta virus, demand for COVID-19 testing is on the rise again, and several at-home tests that have been approved for emergency use authorization are becoming more popular. But should you rely on a test that you administer yourself to tell you whether you have COVID-19? Dr. Matthew Binnicker explains the pros and cons of at-home tests.

By Tracy Will • September 1, 2021

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Clinical Microbiology.

By MCL Education • August 13, 2021

In the wake of the CDC withdrawing its emergency use authorization request for a coronavirus PCR test, social media posts claimed the action signaled that the tests were flawed. Dr. Matthew Binnicker explains why those claims are false.

By Tracy Will • August 4, 2021

Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory in Mayo Clinic’s Division of Clinical Microbiology, considers the prospects for COVID-19 this fall as the traditional influenza season ramps up.

By Tracy Will • July 26, 2021

Elitza Theel, Ph.D., director of Mayo Clinic’s Infectious Disease Serology Lab was featured in a discussion on NBC News about COVID-19 antibody tests.

By Tracy Will • July 20, 2021